Arix Bioscience (ARIX:LSE) Investor Relations Material

Overview

Arix Bioscience is a venture capital company with a focus on the cutting-edge advances in the life sciences industry. The company collaborates with innovative entrepreneurs to invest in and build breakthrough biotech companies that develop treatments for patients. Arix Bioscience provides its investee companies with capital, expertise, and global networks to accelerate the development of life-saving treatments. As a listed company, Arix Bioscience is able to provide exciting growth opportunities for a wider range of investors.

Frequently Asked Questions

What is Arix Bioscience's ticker?

Arix Bioscience's ticker is ARIX

What exchange is Arix Bioscience traded on?

The company's shares trade on the LSE stock exchange

Where are Arix Bioscience's headquarters?

They are based in London, England

How many employees does Arix Bioscience have?

There are 11-50 employees working at Arix Bioscience

What is Arix Bioscience's website?

It is https://arixbioscience.com

What type of sector is Arix Bioscience?

Arix Bioscience is in the Healthcare sector

What type of industry is Arix Bioscience?

Arix Bioscience is in the Biotechnology industry

Who are Arix Bioscience's peers and competitors?

The following five companies are Arix Bioscience's industry peers:

- Reata Pharmaceuticals

- Cellmid Limited

- Harpoon Therapeutics

- 89Bio

- Exopharm Limited